DXS International plc : Half-yearly report


DXS INTERNATIONAL PLC

Half-Yearly Report

The Directors of DXS International plc are pleased to announce the results of the Company for the six month period ending 31st October 2011.

The half year to October shows the anticipated decline in DXS's traditional revenues from the Pharmaceutical sector, caused by reorganisation within that sector.  The decline has now halted.  

In the meantime, the highly anticipated new revenue stream for the newly formed Clinical Commissioning Groups (CCG's), which are replacing traditional Primary Care Trusts (PCT's), has begun. This is as a result of DXS signing an integration agreement with EMIS, the UK's largest provider of patient record systems to primary care, plus the new enhancements to the DXS technology catering to specific CCG needs. The result is an exciting solution helping CCGs to achieve their QIPP (Quality, Innovation, Productivity and Prevention) agenda, which is reducing costs without adversely affecting healthcare outcomes. The bottom line is that DXS now enables a CCG to deliver its recommended treatment guidelines, referral forms and guides, patient and professional education, a directory of qualified service providers and prescribing guides to its clinicians during a patient consultation.

DXS has thus far signed five CCGs to the basic care pathway service and DXS hopes to double this number by the end of the financial year in April.  Taking into account the effect of the new CCG contracts (whose turnover is not represented in these results), DXS's current level of monthly revenue generation is expected to exceed £1.55m p.a.  With more than 250 CCG's and Health Boards throughout the UK, the potential growth for DXS over the next few years is indeed exciting.

Our immediate focus now is on a targeted sales and marketing campaign with increased resources in content management and training to support the new emerging market.

Yours sincerely

David Immelman

CEO

INTERIM RESULTS TO 31st OCTOBER 2012

CONSOLIDATED PROFIT AND LOSS ACCOUNT

for the six month period ended 31st October 2012

Unaudited
6 Months ended
31st Oct 2012
Unaudited
6 Months ended
31st Oct 2011
Audited
Year to
30th April 2012
£ £ £
Turnover 668,009 770,468 1,404,997
Cost of Sales (163,606) (281,668) (390,529)
504,403 488,800 1,014,468
Administrative Expenses (484,143) (467,894) (959,051)
Goodwill written off (14,253) (14,253) (28,505)
Operating Profit/(loss) 6,007 6,653 26,912
Other interest receivable and similar income 871 788 1,618
Interest payable and similar charges (4,855) (5,721) (10,108)
Profit/ (Loss) on Ordinary Activities before taxation 2,023 1,720 18,422
Tax on Profit on ordinary activities 0 0 51,169
Profit/ (Loss) for the period 2,023 1,720 69,591
Profit/ (Loss) per share 0.0p 0.0p 0.3p

CONSOLIDATED BALANCE SHEET

as at 31st October 2012

Unaudited

31st Oct 2012
Unaudited

31st Oct 2011
£ £
Fixed Assets
Intangible Assets 1,955,071 701,052
Tangible Assets 4,048 18,935
Investment - -
1,959,119 719,987
Current assets
Debtors 368,346 377,931
Cash at bank and in hand 48,440 114,646
416,786 492,577
Creditors: amounts falling due within one year (739,849) (486,976)
Net current assets/ liabilities (323,063) 5,601
Total assets less current liabilities 1,636,056 725,588
Creditors: amounts falling due after more than one year (956,348) (115,774)
679,9080 609,814
Capital and reserves
Called up share capital 92,8450 92,845
Share Premium account 776,054 776,054
Profit and loss account (189,191) (259,085)
679,708 609,814

The above figures have not been reviewed by the company's auditors LDP Luckmans.

The Directors of DXS International plc accept responsibility for this announcement.

Contact Information:

David Immelman
Unit 6a, Abbey Business Park,
Monks Walk, Farnham,
Surrey
GU9 8HT

Tel: 01252 719800
Website: www.dxs-systems.com

Corporate Adviser:

David Papworth
City & Merchant Limited,
Salisbury House,
29 Finsbury Circus,
London
EC2M 5QQ
Tel: 020 7101 7676

GlobeNewswire

Recommended Reading